Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2114284rdf:typepubmed:Citationlld:pubmed
pubmed-article:2114284lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:2114284lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:2114284lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:2114284pubmed:issue1lld:pubmed
pubmed-article:2114284pubmed:dateCreated1990-8-13lld:pubmed
pubmed-article:2114284pubmed:abstractTextThe synthetic D-galactose analog 2-deoxy-2-fluoro-D-galactose (dGalF) offers unique advantages for studies of the D-galactose pathway by non-invasive techniques using 19F-NMR spectroscopy or positron emission from the 18F-labeled compound. The metabolism of 2-deoxy-2-fluoro-D-galactose was studied in rodents using the unlabeled, the 18F-labeled, and the 14C-labeled D-galactose analog. Analyses for the metabolites of 2-deoxy-2-fluoro-D-galactose were performed by HPLC, enzymatic methods, and 19F-NMR spectroscopy in vivo and in vitro. The metabolism of 2-deoxy-2-fluoro-D-galactose was most active in the liver which took up the major part of the administered dose of the 14C-labeled D-galactose analog, but renal excretion was also pronounced. This was confirmed by in vivo scanning of the rat using the 18F-labeled sugar (1.5 microCi/g; 25 nmol/g) and examination by positron-emission tomography and gamma camera. The dose dependence of the levels of the hepatic metabolites of 2-deoxy-2-fluoro-D-galactose was investigated for doses between 25 nmol/g body mass and 1 mumols/g body mass. After 1 h, the major part of the acid-soluble uracil nucleotides consisted of UDP-2-deoxy-2-fluoro-D-hexoses when the dose was at least 0.1 mumols/g. With higher doses, 2-deoxy-2-fluoro-D-galactose 1-phosphate became the predominant initial metabolite. After a dose of 1 mumols/g 2-deoxy-2-fluoro-D-galactose 1-phosphate accumulated rapidly (5.3 +/- 0.4 mumols/g liver after 30 min) followed by the formation of UDP-2-deoxy-2-fluoro-D-galactose and UDP-2-deoxy-2-fluoro-D-glucose (0.7 +/- 0.1 mumols/g and 1.8 +/- 0.1 mumols/g, respectively, after 5 h). The diversion of uridylate, due to the accumulation of UDP-2-deoxy-2-fluoro-D-hexoses, was associated with a rapid depletion of hepatic UTP, UDP-glucose, and UDP-galactose. The UTP content was decreased to 11 +/- 6% of normal within 15 min after administration of 2-deoxy-2-fluoro-D-galactose at a dose of 1 mumols/g. The UTP-depleting action was minimal, however, at a dose of 25 nmols/g or less, indicating that interference in uridylate metabolism would be negligible at the doses required for positron-emission tomography of the liver using the 18F-labeled compound. At higher doses, the UTP deficiency induced by 2-deoxy-2-fluoro-D-galactose could be useful in the chemotherapy of D-galactose-metabolizing tumors such as hepatocellular carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2114284pubmed:languageenglld:pubmed
pubmed-article:2114284pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2114284pubmed:citationSubsetIMlld:pubmed
pubmed-article:2114284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2114284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2114284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2114284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2114284pubmed:statusMEDLINElld:pubmed
pubmed-article:2114284pubmed:monthMaylld:pubmed
pubmed-article:2114284pubmed:issn0014-2956lld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:FriedrichEElld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:HullW EWElld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:LehmannJJlld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:BergerUUlld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:OstertagHHlld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:KepplerDDlld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:OberdorferFFlld:pubmed
pubmed-article:2114284pubmed:authorpubmed-author:GwonA EAElld:pubmed
pubmed-article:2114284pubmed:issnTypePrintlld:pubmed
pubmed-article:2114284pubmed:day31lld:pubmed
pubmed-article:2114284pubmed:volume190lld:pubmed
pubmed-article:2114284pubmed:ownerNLMlld:pubmed
pubmed-article:2114284pubmed:authorsCompleteYlld:pubmed
pubmed-article:2114284pubmed:pagination11-9lld:pubmed
pubmed-article:2114284pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:meshHeadingpubmed-meshheading:2114284-...lld:pubmed
pubmed-article:2114284pubmed:year1990lld:pubmed
pubmed-article:2114284pubmed:articleTitleMetabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo.lld:pubmed
pubmed-article:2114284pubmed:affiliationDeutsches Krebsforschungszentrum, Heidelberg, Federal Republic of Germany.lld:pubmed
pubmed-article:2114284pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2114284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2114284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2114284lld:pubmed